Explore our Research Blog
PD Dr. Jan-Henning Klusmann is a co-winner of the 2017 Robert J. Arceci Award, a unique prize that offers resources and freedom to pioneers and innovators in childhood cancer research.
We provide a non-coding RNA expression atlas across normal and malignant blood formation. Our data highlight the biological and clinical importance of ncRNAs, and the necessity of further functional studies.
We are looking for an enthusiastic, proactive and creative team player capable of developing and performing experiments independently. Experience with tissue culture and molecular biology preferred.
Results from the international ML-DS 2006 trial indicate that children with Down syndrome acute myeloid leukemia can be cured with a less intensive, less cytotoxic treatment regime.
All five of our PhD students showed posters at the ISALXVI in Munich. Dorit was further selected as a Best of Free Contributions and gave a talk and interview about her research.
The Evangelische Johannesstift donated 364,000 Euros to fund research on early childhood leukemias. The funds were given to PD Dr. Klusmann of the Department of Pediatric Hematology and Oncology.
Dr. Jan-Henning Klusmann has received the 10,000 Euro Kind-Philipp Prize, in appreciation of his research work on childhood blood cancers at the Hannover Medical School.
Dr. Klusmann's research group reveals the interplay between three microRNAs in the development of acute megakaryoblastic leukemia. Their findings were published in Genes & Development.